About Deborah
Deborah S. Birnbach: Leading Complex Litigation & M&A Attorney
Deborah S. Birnbach is a highly respected partner and co-chair of Goodwin’s Complex Litigation & Dispute Resolution and Public M&A / Corporate Governance practices. As a member of the firm’s Life Sciences Disputes group, she specializes in providing sophisticated legal counsel across a broad spectrum of complex litigation matters, with a national scope and a commitment to achieving the best possible outcomes for her clients.
Ms. Birnbach’s expertise encompasses securities litigation, including aggressive class action defense, intricate SEC investigations and regulatory matters, and high-stakes M&A-related disputes. She’s a leading voice in stockholder disputes, fiduciary duty claims, and proxy contests, consistently representing public and private companies, boards, officers, and private equity firms with significant involvement in healthcare, life sciences, and technology sectors.
Her practice focuses on defending clients against allegations of serious misconduct, including insider trading, misleading disclosures, deficiencies in M&A transactions, insufficient deal consideration, improper revenue recognition, and various breaches of fiduciary duty. She’s adept at navigating complex accounting irregularities and skillfully representing clients in situations involving self-dealing and other financial improprieties. Ms. Birnbach’s collaborative approach, combined with her deep understanding of corporate governance, makes her a trusted advisor to organizations facing significant legal challenges.
With colleagues within the Public M&A / Corporate Governance Practice, Ms. Birnbach actively supports integrated deal teams, representing targets, acquirers, and their financial advisors throughout M&A transactions. She’s a skilled counselor on litigation avoidance, leveraging arbitration, mediation, and other alternative dispute resolution methods to minimize risk and achieve favorable resolutions.
Recognizing the importance of proactive oversight, Ms. Birnbach frequently conducts internal corporate investigations for audit committees and other board committees in financial accounting and corporate governance matters. This includes expertise in whistleblower investigations under the Sarbanes-Oxley and Dodd-Frank Acts, ensuring thorough and impartial reviews of potential misconduct. She also represents clients in FINRA inquiries and regulatory proceedings brought by the SEC and other agencies, addressing concerns about accounting irregularities, corporate disclosures to investors, and insider trading activities.
Ms. Birnbach’s leadership extends beyond her practice; she previously served on the firm’s Executive Committee and was formerly co-chair of Goodwin’s Women’s Initiative. She currently serves on the firm’s Allocations Committee, demonstrating her commitment to innovation and strategic growth. Her dedication to excellence and her significant contributions to the firm underscore her position as a leading legal strategist.
Practice Areas:
- Arbitration
- Biotechnology and Life Sciences Practice
- Litigation - Regulatory Enforcement (SEC, Telecom, Energy
- Litigation - Securities
- Commercial Litigation
- Litigation - Mergers and Acquisitions
Awards & Recognition:
- Recognized: Arbitration
- Recognized: Biotechnology and Life Sciences Practice
- Recognized: Litigation - Regulatory Enforcement (SEC, Telecom, Energy
- Recognized: Litigation - Securities
- Practice Area: Commercial Litigation
- Practice Area: Litigation - Mergers and Acquisitions
Education & Credentials:
- Bar Admissions: Massachusetts (and national scope)
- Best Attorney USA: Recognized Since 2019
Affiliations:
Boston, Massachusetts, United States
